Literature DB >> 17010150

Distribution and dynamic changes of sphingolipids in blood in response to platelet activation.

F Dahm1, A Nocito, A Bielawska, K S Lang, P Georgiev, L M Asmis, J Bielawski, J Madon, Y A Hannun, P-A Clavien.   

Abstract

BACKGROUND: Sphingolipids are signaling molecules in a range of biological processes. While sphingosine-1-phosphate (S1P) is thought to be abundantly stored in platelets and released upon stimulation, knowledge about the distribution and function of other sphingolipids in blood is lacking.
OBJECTIVES: To analyze the sphingolipid content of blood components with special emphasis on dynamic changes in platelets.
METHODS: Blood components from mice and humans were prepared by gradient centrifugation and analyzed by liquid chromatography-mass spectrometry. Additionally, murine platelets were activated in vitro and in vivo.
RESULTS: Isolated non-activated platelets of mice were devoid of S1P, but instead contained dihydrosphingosine-1-phosphate (dhS1P), along with a high concentration of ceramide. Activation of platelets in vitro led to a loss of dhS1P and an increase in sphingosine, accompanied by a reduction of ceramide content. Platelet activation in vivo led to an immediate and continuous rise of dhS1P in plasma, while S1P remained stable. The sphingolipid distribution of human blood was markedly different from mice. Human platelets contained dhS1P in addition to S1P.
CONCLUSIONS: Mouse platelets contain dhS1P instead of S1P. Platelet activation causes loss of dhS1P and breakdown of ceramide, implying ceramidase activation. Release of dhS1P from activated platelets might be a novel signaling pathway. Finally, the sphingolipid composition of mouse and human blood shows large differences, which must be considered when studying sphingolipid biology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010150     DOI: 10.1111/j.1538-7836.2006.02241.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

1.  Endothelial alterations in a canine model of immune thrombocytopenia.

Authors:  Dana N LeVine; Rachel E Cianciolo; Keith E Linder; Petra Bizikova; Adam J Birkenheuer; Marjory B Brooks; Abdelghaffar K Salous; Shila K Nordone; Dwight A Bellinger; Henry Marr; Sam L Jones; Thomas H Fischer; Yu Deng; Marshall Mazepa; Nigel S Key
Journal:  Platelets       Date:  2017-11-28       Impact factor: 3.862

2.  Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.

Authors:  U Hofmann; K Hu; F Walter; N Burkard; G Ertl; J Bauersachs; O Ritter; S Frantz; A Bonz
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 3.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

4.  Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function.

Authors:  Jose Greenspon; Ruiyun Li; Lan Xiao; Jaladanki N Rao; Rex Sun; Eric D Strauch; Terez Shea-Donohue; Jian-Ying Wang; Douglas J Turner
Journal:  Dig Dis Sci       Date:  2010-10-09       Impact factor: 3.199

Review 5.  Sources, metabolism, and regulation of circulating sphingosine-1-phosphate.

Authors:  Monika Książek; Marta Chacińska; Adrian Chabowski; Marcin Baranowski
Journal:  J Lipid Res       Date:  2015-05-26       Impact factor: 5.922

Review 6.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

Review 7.  Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets.

Authors:  Valerie B O'Donnell; Robert C Murphy; Steve P Watson
Journal:  Circ Res       Date:  2014-03-28       Impact factor: 17.367

8.  Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice.

Authors:  F Dahm; A Bielawska; A Nocito; P Georgiev; Z M Szulc; J Bielawski; W Jochum; D Dindo; Y A Hannun; P-A Clavien
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

9.  High-density lipoprotein induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through sphingosine kinase-2.

Authors:  Sheng-Lin Xiong; Xing Liu; Guang-Hui Yi
Journal:  Mol Cell Biochem       Date:  2014-01-03       Impact factor: 3.396

10.  Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.

Authors:  Małgorzata Knapp; Małgorzata Zendzian-Piotrowska; Agnieszka Błachnio-Zabielska; Piotr Zabielski; Krzysztof Kurek; Jan Górski
Journal:  Basic Res Cardiol       Date:  2012-09-09       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.